Public Health Emergency of International Concern
Also called: PHEIC · Topic: Natural Hazards and Disaster Management in India · NCERT: Beyond NCERT
Meaning
A Public Health Emergency of International Concern (PHEIC) is a formal declaration by the World Health Organization (WHO) under the International Health Regulations (2005). It says that an unusual disease event could spread to other countries and needs countries to act together. The WHO Director-General makes the declaration after an IHR Emergency Committee of experts gives advice.
- It is the world's highest formal health alarm. It brings money, vaccines and expert teams to the affected area.
- In disaster geography it matters because epidemics are biological disasters, one of NCERT's four classes of natural disasters.
Explanation
The legal base: International Health Regulations (2005)
- The International Health Regulations (IHR) are WHO's legally binding rules. They set out how countries must report and respond to health events that can cross borders.
- The 2026 Bundibugyo Ebola outbreak was declared a PHEIC under the IHR (2005). It covers the DRC and Uganda.
- Under the IHR, an event counts as a PHEIC when it is:
- extraordinary (not a normal, routine outbreak),
- a public health risk to other countries through international spread, and
- likely to need a coordinated international response.
How a PHEIC is declared (step by step)
- An outbreak is reported. The affected country tells WHO.
- The Director-General decides to declare. For the 2026 Bundibugyo outbreak, this happened on 17 May 2026.
- The IHR Emergency Committee meets. It is a panel of independent experts. Its first meeting came on 19 May 2026.
- The Committee meets again and reviews the emergency. Its second statement came on 20 August 2026.
- WHO issues temporary recommendations. These cover surveillance, travel, border checks and the response. They are advice and do not force countries. - Key point: the Director-General decides. The Emergency Committee only advises.
What a PHEIC sets in motion
- Multilateral coordination: WHO, Africa CDC, the ICG vaccine stockpile and the IHR Emergency Committees all have roles.
-
The ICG (International Coordinating Group on Vaccine Provision) holds emergency vaccine stocks.
-
Vaccines released from stockpiles: the ICG gave the DRC 20,000 doses for a Phase 3 trial and 50,000 doses for frontline and health workers.
-
A Phase 3 trial is a large test of whether a vaccine protects people.
-
Emergency money: early in the response, WHO released US$3.9 million from its Contingency Fund for Emergencies (CFE), a small pool WHO can spend at once.
- Research under trial rules: an unproven vaccine (Ervebo) is used only inside a randomised trial. In such a trial, chance decides who gets the vaccine, so results can be compared fairly.
Limits of the mechanism
- A PHEIC is not the same as high global risk. WHO rated the 2026 risk very high in the DRC, high for neighbouring countries, but low at regional and global level.
- It cannot create tools that do not exist. There is no licensed vaccine or specific treatment for Bundibugyo virus disease.
- Vaccines come too late. New vaccines take years, and outbreaks move in weeks.
- In 2022, vaccines reached Uganda 79 days after its Sudan-virus outbreak was declared.
-
The outbreak ended first (164 cases, 77 deaths), so the trial never started.
-
Ordinary measures still end outbreaks. Contact tracing and isolation stop the spread while vaccines are still being tested.
Where it occurs
- World, 2026: DRC and Uganda (Great Lakes region, Africa)
- Ebola caused by the Bundibugyo virus was declared a PHEIC on 17 May 2026.
- The epicentre is Ituri province. North Kivu is the second most affected.
- By 23 September 2026 it had spread to 63 health zones in 7 provinces: 7,890 confirmed cases, 3,799 deaths, case fatality rate (CFR, the share of cases who die) 48.1%.
- Uganda had imported cases and limited local transmission.
-
This is the DRC's second Bundibugyo outbreak. The first was in 2012.
-
Who runs it: WHO, under the IHR (2005), at its headquarters in Geneva, together with Africa CDC and the ICG.
- India
- Epidemics are biological disasters in NCERT Class 11, Table 6.1, alongside bird flu and dengue.
- COVID-19, which WHO had declared a PHEIC, was notified as a disaster under India's Disaster Management Act 2005 in March 2020.
- The Serum Institute of India is working with Oxford on a Bundibugyo vaccine candidate. It was in a Phase 1 trial in the UK from July 2026.
Don't confuse with
- Pandemic: a pandemic is a disease that has spread across many countries and continents. A PHEIC is a legal declaration that can be made early, even when the global risk is still rated low.
- Notified disaster under the DM Act 2005: this is an Indian legal step taken by Indian authorities. A PHEIC is an international declaration made by the WHO Director-General.
- IHR Emergency Committee: the Committee advises. Only the Director-General declares a PHEIC.
- Licensed vaccine coverage: Ervebo is licensed and WHO-prequalified only for the Zaire species of Ebola, not Bundibugyo. A PHEIC does not mean a vaccine exists.
Prelims Hooks
- A PHEIC is declared under the International Health Regulations (2005) by the WHO Director-General, after the IHR Emergency Committee advises.
- The 2026 Bundibugyo Ebola PHEIC was declared on 17 May 2026 and covers DRC and Uganda.
- Trap: "A PHEIC means WHO rates the global risk as high." False. In 2026 the global risk was rated low, while the DRC was rated very high.
- Trap: "Ervebo protects against all Ebola viruses." False. It covers Zaire ebolavirus only.
- Epidemics (bird flu, dengue) fall under biological disasters in NCERT Table 6.1, not atmospheric or terrestrial.
- COVID-19 was notified as a disaster under India's DM Act 2005 in March 2020.
Mains Points
- Strengths and gaps of the PHEIC mechanism (GS-III disaster management)
- Strength: it brings coordination and resources together, such as ICG doses (20,000 trial + 50,000 frontline) and WHO's CFE money.
-
Gaps: no licensed Bundibugyo vaccine exists. Funding was small, since the CFE's US$3.9 million is about one-tenth of the $36 million research award. And vaccines arrive late, as Uganda's 79-day delay in 2022 showed.
-
Reforms: be ready before the outbreak starts
- Keep trial protocols approved in advance, and keep candidate doses ready, as was done for Sudan virus in Uganda in 2025.
- Plan a vaccine stockpile once any Bundibugyo vaccine is proven to work.
-
Fund contact tracing and isolation with fast, flexible money.
-
Lessons for India
- Treat epidemics as biological disasters inside the DM Act 2005 system (NDMA, SDMAs, DDMAs), as was done with COVID-19 in March 2020.
- Use Indian vaccine makers' large-scale production, such as the Serum Institute's Bundibugyo candidate, to support vaccine equity in Africa.